SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $717K invested in Scinai Immunotherapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$653K
2
+$51.9K
3
+$1.66K

Top Sellers

1
-$58K
2
-$34K
3
-$13K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$10K
5
Millennium Management
Millennium Management
New York
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$653K
2
$51.9K
3
$8.34K
4
$1.25K
5
$1K
6
$888
7
$474
8
$148
9
$59
10
$6
11
–
12
–
13
–
14
–
15
–